Agenda

Each presentation will incorporate a minimum of 5 minutes dedicated to interactive elements. These can be Q&A, discussion with the audience, and/or polling questions incorporated into the speaker presentations.

8:00 Welcome and Introductions
Dr. Christine Chen
8:10 BCMA-targeted CAR T-cell therapy in myeloma – Coming soon
Dr. Yi Lin (Guest speaker Mayo Clinic, NY)
9:00 Nephro-oncology and myeloma
Dr. Abhi Kitchlu (Guest speaker UHN, Toronto)
9:50 Management of early relapse
Dr. Suzanne Trudel
10:30 Break
10:45 Small Group Case-Based Breakout Sessions

Small group sessions are fully interactive between faculty and participants. For planning purposes, pre-registration for workshops is required.

  1. Relapsed/refractory myeloma
    Drs. Suzanne Trudel and Sita Bhella
  2. Immunotherapy – CAR T and bispecifics
    Drs. Yi Lin, Guido Lancmann, S. Shih
  3. Frontline myeloma therapy
    Drs. Keith Stewart and R. Sharma
  4. Nephro-oncology in myeloma
    Drs. Abhi Kitchlu and Christine Chen
  5. Amyloidosis
    Drs.Vishal Kukreti and Donna Reece
  6. Supportive care: Immunization strategies in myeloma
    Drs. V. Hall (UHN Transplant ID), A. Sanchez Hernandez, Badraa Maharib (Fellows), Duke Boampong (Pharmacy)
12:15 Lunch break
1:00 Updates in frontline therapy
Dr. Keith Stewart
1:30 Practical management of bispecific antibodies
Dr. Guido Lancmann
2:00 COVID vaccination in MM – lessons learned
Dr. Sita Bhella
2:30 Closing Remarks and Evaluation
Dr. Christine Chen